Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Biomol Screen ; 12(2): 248-54, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17259590

ABSTRACT

Cryopreserved, transiently transfected HepG2 cells were compared to freshly transfected HepG2 cells for use in a pregnane X receptor (PXR) transactivation assay. Assay performance was similar for both cell preparations; however, cryopreserved cells demonstrated less interassay variation. Validation with drugs of different PXR activation potencies and efficacies demonstrated an excellent correlation (r(2) > 0.95) between cryopreserved and fresh cells. Cryopreservation did not change the effect of known CYP3A4 inducers that have poor cell permeability, indicating that cryopreservation had little effect on membrane permeability. In addition, cryopreserved HepG2 cells did not exhibit enhanced susceptibility to cytotoxic compounds compared to transiently transfected control cells. The use of cryopreserved cells enables this assay to run with enhanced efficiency.


Subject(s)
Biological Assay/methods , Cryopreservation/methods , Pharmaceutical Preparations/metabolism , Receptors, Steroid/metabolism , Transcriptional Activation , Caco-2 Cells , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Cell Membrane Permeability/drug effects , Drug-Related Side Effects and Adverse Reactions , Humans , Liver Neoplasms/pathology , Mifepristone/metabolism , Mifepristone/pharmacology , Pregnane X Receptor , Receptors, Steroid/agonists , Receptors, Steroid/antagonists & inhibitors , Reproducibility of Results , Rifampin/metabolism , Rifampin/pharmacology , Sulfinpyrazone/metabolism , Sulfinpyrazone/pharmacology , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...